Zauatbayeva, G. ., L. Syzdykova, V. . Keyer, A. Shustov, A. Abilmagzhanov, and M. Zhurynov. “NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS”. Eurasian Journal of Applied Biotechnology, no. 2, July 2022, pp. 44-53, doi:10.11134/btp.2.2022.7.